HEYMANS, STEPHANE
 Distribuzione geografica
Continente #
AS - Asia 1.300
NA - Nord America 1.193
EU - Europa 904
SA - Sud America 136
AF - Africa 30
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.569
Nazione #
US - Stati Uniti d'America 1.151
SG - Singapore 543
RU - Federazione Russa 453
CN - Cina 255
VN - Vietnam 243
IT - Italia 140
BR - Brasile 112
HK - Hong Kong 110
DE - Germania 73
NL - Olanda 56
FR - Francia 55
FI - Finlandia 49
IN - India 25
CA - Canada 23
BD - Bangladesh 22
GB - Regno Unito 22
JP - Giappone 19
PH - Filippine 18
ZA - Sudafrica 12
MX - Messico 11
TH - Thailandia 10
IQ - Iraq 9
KR - Corea 9
ID - Indonesia 8
IE - Irlanda 8
EC - Ecuador 7
TR - Turchia 7
AT - Austria 6
BG - Bulgaria 6
CI - Costa d'Avorio 6
UA - Ucraina 6
BE - Belgio 5
ES - Italia 5
PK - Pakistan 5
PL - Polonia 4
AR - Argentina 3
CL - Cile 3
CO - Colombia 3
LT - Lituania 3
PY - Paraguay 3
SE - Svezia 3
SK - Slovacchia (Repubblica Slovacca) 3
AZ - Azerbaigian 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
PE - Perù 2
SA - Arabia Saudita 2
SD - Sudan 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AD - Andorra 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
FJ - Figi 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HT - Haiti 1
JM - Giamaica 1
KE - Kenya 1
LC - Santa Lucia 1
LV - Lettonia 1
NC - Nuova Caledonia 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RE - Reunion 1
SR - Suriname 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.569
Città #
Singapore 253
San Jose 179
Ashburn 152
Chandler 108
Hong Kong 104
Moscow 101
Beijing 73
Ho Chi Minh City 64
Hanoi 55
Hefei 53
Amsterdam 47
Santa Clara 45
Los Angeles 30
New York 30
The Dalles 27
Lauterbourg 26
Lappeenranta 23
Naples 22
Helsinki 21
Frankfurt am Main 20
Millbury 20
Des Moines 19
Tokyo 18
Lawrence 16
Da Nang 15
Dallas 15
Redondo Beach 15
Council Bluffs 14
Washington 14
Haiphong 13
Munich 13
Nanjing 13
Seattle 12
Augusta 11
Buffalo 11
Falkenstein 11
Nuremberg 11
São Paulo 11
Boston 10
Chennai 8
Milan 8
Princeton 8
Seoul 8
Atlanta 7
Houston 7
Napoli 7
Brooklyn 6
Denver 6
Mexico City 6
Montreal 6
Orem 6
Sofia 6
Toronto 6
Wilmington 6
Germantown 5
Quận Bình Thạnh 5
Rome 5
Roubaix 5
Trieste 5
Turin 5
Ankara 4
Bandung 4
Cervia 4
Chicago 4
Dong Ket 4
Guangzhou 4
Johannesburg 4
Ninh Bình 4
Phoenix 4
Rho 4
Tianjin 4
Turku 4
Tân Tiến 4
Woodbridge 4
Asunción 3
Baghdad 3
Bangkok 3
Brasília 3
Bắc Giang 3
Charlotte 3
Chengdu 3
Chon Buri 3
Dublin 3
Düsseldorf 3
Fairfield 3
Hebei 3
Hải Dương 3
Istanbul 3
Kosice 3
Lima 3
London 3
Madrid 3
Manchester 3
Poplar 3
Porto Alegre 3
San Mateo 3
Shanghai 3
Shenyang 3
Shenzhen 3
Stockholm 3
Totale 1.960
Nome #
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function 180
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart 158
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart 151
The role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a Position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC) 144
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 139
An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology 138
The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology 135
Integrating Cardiac PIP3 and cAMP Signaling through a PKA Anchoring Function of p110γ 135
Immunometabolic Mechanisms of Heart Failure with Preserved Ejection Fraction 135
The innate immune system in chronic cardiomyopathy: A European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC 134
Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology 134
Complex Roads from Genotype to Phenotype in Dilated Cardiomyopathy: Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology 134
Common Mechanistic Pathways in Cancer and Heart Failure 132
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology 128
KiDS-450: cosmological parameter constraints from tomographic weak gravitational lensing 123
Reciprocal organ interactions during heart failure-a position paper from the ESC working group on myocardial function 119
The continuous heart failure spectrum: moving beyond an ejection fraction classification 118
Non-coding RNAs - Update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart 118
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 118
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function 118
Treatments targeting inotropy 111
Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology. 106
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function 105
Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology – Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications 97
Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart 92
Pathophysiology of Takotsubo Syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 1: Overview and the central role for catecholamines and sympathetic nervous system 78
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases 76
Myocarditis Following SARS-CoV2 mRNA Vaccination Against COVID-19: Facts and Open Questions 75
Circulating c-Met-Expressing Memory T Cells Define Cardiac Autoimmunity 74
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC 64
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: From molecular mechanisms to therapeutic targets 63
Totale 3.632
Categoria #
all - tutte 11.219
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.219


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022146 1 2 0 3 10 4 15 4 4 12 42 49
2022/2023270 25 21 18 7 32 25 2 21 48 52 11 8
2023/2024235 4 25 27 32 24 48 1 19 1 12 30 12
2024/2025989 46 26 8 7 14 108 86 60 71 118 363 82
2025/20261.836 217 139 195 189 284 60 178 90 257 136 79 12
Totale 3.632